The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Cugene; Equillium; Mallinckrodt; Moderna Therapeutics
Research Funding - Bristol-Myers Squibb; Miltenyi Biotec; Regeneron
Expert Testimony - Abbvie
Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Marcelo C. Pasquini
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Celgene; Medigene (Inst); Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Kite/Gilead; Novartis
 
Edward Allen Stadtmauer
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Sanofi; Takeda; Teva
 
Raphael Fraser
No Relationships to Disclose
 
Mingwei Fei
No Relationships to Disclose
 
Steven Michael Devine
Honoraria - Kiadis Pharma
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Kiadis Pharma (Inst); Orca Bio (Inst)
Travel, Accommodations, Expenses - Orca Bio
 
Yvonne Adeduni Efebera
No Relationships to Disclose
 
Nancy Geller
No Relationships to Disclose
 
Mary M. Horowitz
Consulting or Advisory Role - Janssen Research & Development (Inst); Magenta Therapeutics (Inst); Medac (Inst)
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Amneal Pharmaceuticals (Inst); Anthem (Inst); Biovitrum (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Chimerix (Inst); CSL Behring (Inst); Cyto-Sen Therapeutics (Inst); Daiichi Sankyo (Inst); Gamida Cell (Inst); GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); Magenta Therapeutics (Inst); Mesoblast (Inst); Miltenyi Biotec (Inst); Neovii (Inst); Novartis (Inst); Oncoimmune (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sanofi (Inst); Seagen (Inst); Shire (Inst)
 
John Koreth
No Relationships to Disclose
 
Heather Jolie Landau
Consulting or Advisory Role - Caelum Biosciences; Celgene; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Takeda
Research Funding - Takeda
 
Philip L. McCarthy
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; The Binding Site
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Magenta Therapeutics; Sanofi; The Binding Site
Research Funding - Celgene (Inst)
 
Muzaffar H. Qazilbash
Consulting or Advisory Role - BioClinica; Genzyme
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Gilead Sciences; Johnson & Johnson; Lilly; Novartis
Honoraria - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
 
Dan T. Vogl
Consulting or Advisory Role - Active Biotech; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Active Biotech
 
George Somlo
No Relationships to Disclose
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Sutter Medical Group
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi